Nuokang Biopharma realized 15% revenues growth in the 4th quarter of 2009 and net income RMB ***m. Hemocoagulase brand of this company is very popular in China hematological market……
The largest synthetic drug base locates in Haimen. Shanghai Modern Pharmaceutical Co., Ltd. has invested *.* billion yuan on this project……
China health minister told reporters that China is trying to ensure more than 90 percent of the Chinese have health insurance in the near future……
WuXi PharmaTech Signs agreement With J&J subsidy for preclinical GLP and toxicology services in its Suzhou facility. By mid 2010……
News 
